The etiology of cleft palate: A 50-year search for mechanistic and molecular understanding

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 89, Issue 4, 2010, Pages 266-274

  Abbott, Barbara D ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Birth defects; Cleft palate; Palatogenesis

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CORTISONE; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR RECEPTOR; HYDROCORTISONE; RETINOL; TERATOGENIC AGENT; TRANSFORMING GROWTH FACTOR BETA3; TRIAMCINOLONE;

BIRTH DEFECT; CELL FATE; CLEFT PALATE; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HIGH RISK PATIENT; HUMAN; INCIDENCE; MOLECULAR MECHANICS; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SIGNAL TRANSDUCTION; TERATOGENESIS;

ANIMALS; CELL DIFFERENTIATION; CLEFT PALATE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; MICE; PALATE; TERATOGENS;

EID: 77955871792     PISSN: 15429733     EISSN: 15429741     Source Type: Journal    
DOI: 10.1002/bdrb.20252     Document Type: Review

References (62)

1. Abbott BD. 2002. Experimental models for the study of oral clefts. In: Wyszynski DF, editor. Cleft lip and palate: from origin to treatment. New York: Oxford University Press. p 193-202.
2. Abbott BD, Best DS, Narotsky MG. 2005a. Teratogenic effects of retinoic acid are modulated in mice lacking expression of epidermal growth factor and transforming growth factor-alpha. Birth Defects Res A Clin Mol Teratol 73:204-217.
3. Abbott BD, Buckalew AR, Leffler KE. 2005b. Effects of epidermal growth factor (EGF), transforming growth factor-alpha (TGFalpha), and 2,3,7,8-tetrachlorodibenzo-p-dioxin on fusion of embryonic palates in serum-free organ culture using wild-type, EGF knockout, and TGFalpha knockout mouse strains. Birth Defects Res A Clin Mol Teratol 73:447-454.
4. Birnbaum LS, Weber H, Harris MW, Lamb JCt, McKinney JD. 1985. Toxic interaction of specific polychlorinated biphenyls and 2,3,7,8- tetrachlorodibenzo-p-dioxin: increased incidence of cleft palate in mice. Toxicol Appl Pharmacol 77:292-302.
5. Blavier L, Lazaryev A, Groffen J, Heisterkamp N, DeClerck YA, Kaartinen V. 2001. TGF-beta3-induced palatogenesis requires matrix metalloproteinases. Mol Biol Cell 12:1457-1466.
6. Brunet CL, Sharpe PM, Ferguson MW. 1995. Inhibition of TGF-beta 3 (but not TGF-beta 1 or TGF-beta 2) activity prevents normal mouse embryonic palate fusion. Int J Dev Biol 39:345-355.
7. Bryant PL, Schmid JE, Fenton SE, Buckalew AR, Abbott BD. 2001. Teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the expression of EGF and/or TGF-alpha. Toxicol Sci 62: 103-114.
8. Carette MJ, Ferguson MW. 1992. The fate of medial edge epithelial cells during palatal fusion in vitro: an analysis by DiI labelling and confocal microscopy. Development 114:379-388.
9. Cohlan SQ. 1953. Excessive intake of vitamin A as a cause of congenital anomalies in the rat. Science 117:535-536.
10. Courtney KD, Moore JA. 1971. Teratology studies with 2,4,5- trichlorophenoxyacetic acid and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 20:396-403.
11. Cuervo R, Covarrubias L. 2004. Death is the major fate of medial edge epithelial cells and the cause of basal lamina degradation during palatogenesis. Development 131:15-24.
12. Diewert VM, Pratt RM. 1981. Cortisone-induced cleft palate in A/J mice: failure of palatal shelf contact. Teratology 24:149-162.
13. Dostal M, Jelinek R. 1974. Morphogenesis of cleft palate induced by exogenous factors. VI. The question of delayed palatal-process horizontalization. Teratology 10:47-53.
14. Farbman AI. 1968. Electron microscope study of palate fusion in mouse embryos. Dev Biol 18:93-116.
15. Ferguson MWJ. 1981. Developmental mechanisms in normal and abnormal palate formation with particular reference to the aetiology, pathogenesis and prevention of cleft palate. Br J Orthodont 8:115-137.
16. Ferguson MWJ. 1988. Palate development. Development 103(Suppl):41-60.
17. Ferguson MWJ, Honig LS. 1984. Epithelial-mesenchymal interactions during vertebrate palatogenesis. Curr Topics Dev Biol 19:137-164.
18. Fitchett JE, Hay ED. 1989. Medial edge epithelium transforms to mesenchyme after embryonic palatal shelves fuse. Dev Biol 131:455-474.
19. Fitzpatrick DR, Denhez F, Kondaiah P, Akhurst RJ. 1990. Differential expression of TGF beta isoforms in murine palatogenesis. Development 109:585-595.
20. Fraser FC. 1968. Workshop on embryology of cleft lip and cleft palate. Teratology 1:353-358.
21. Fraser FC, Fainstat TD. 1951. Production of congenital defects in the off-spring of pregnant mice treated with cortisone; progress report. Pediatrics 8:527-533.
22. Fraser FC, Kalter H, Walker BE, Fainstat TD. 1954. The experimental production of cleft palate with cortisone and other hormones. J Cell Physiol Suppl 43:237-259.
23. Greene RM, Kochhar DM. 1973. Spatial relations in the oral cavity of cortisone-treated mouse fetuses during the time of secondary palate closure. Teratology 8:153-161.
24. Greene RM, Pisano MM. 2005. Recent advances in understanding transforming growth factor beta regulation of orofacial development. Hum Exp Toxicol 24:1-12.
25. Griffith CM, Hay ED. 1992. Epithelial-mesenchymal transformation during palatal fusion: carboxyfluorescein traces cells at light and electron microscopic levels. Development 116:1087-1099.
26. Hassell JR. 1975. The development of rat palatal shelves in vitro. An ultrastructural analysis of the inhibition of epithelial cell death and palate fusion by the epidermal growth factor. Dev Biol 45:90-102.
27. Hayward AF. 1969. Ultrastructural changes in the epithelium during fusion of the palatal processes in rats. Archs Oral Biol 14:661-678.
28. Hinrichsen CFL, Stevens GS. 1974. Epithelial morphology during closure of the secondary palate in the rat. Archs Oral Biol 19:969-980.
29. Hudson CD, Shapiro BL. 1973. A radioautographic study of deoxyribonucleic acid synthesis in embryonic rat palatal shelf epithelium with reference to the concept of programmed cell death. Arch Oral Biol 18:77-84.
30. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J. 1995. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11:415-421.
31. Kaartinen V, Cui XM, Heisterkamp N, Groffen J, Shuler CF. 1997. Transforming growth factor-beta3 regulates transdifferentiation of medial edge epithelium during palatal fusion and associated degradation of the basement membrane. Dev Dyn 209:255-260.
32. Kalter H, Warkany J. 1961. Experimental production of congenital malformations in strains of inbred mice by maternal teratment with hypervitaminosis A. Am J Pathol 38:1-21.
33. Kochhar DM, Johnson EM. 1965. Morphological and autoradiographic studies of cleft palate induced in rat embryos by maternal hypervitaminosis A. J Embryol Exp Morphol 14:223-238.
34. Lahti A, Antila E, Saxen L. 1972. The effect of hydrocortisone on the closure of the palatal shelves in two inbred strains of mice in vivo and in vitro. Teratology 6:37-42.
35. Martinez-Alvarez C, Tudela C, Perez-Miguelsanz J, O'Kane S, Puerta J, Ferguson MW. 2000. Medial edge epithelial cell fate during palatal fusion. Dev Biol 220:343-357. (Pubitemid 30228158)
36. Meng L, Bian Z, Torensma R, Von den Hoff JW. 2009. Biological mechanisms in palatogenesis and cleft palate. J Dental Res 88:22-33.
37. Mori C, Nakamura N, Okamoto Y, Osawa M, Shiota K. 1994. Cytochemical identification of programmed cell death in the fusing fetal mouse palate by specific labelling of DNA fragmentation. Anat Embryol (Berl) 190:21-28.
38. Murray JC, Schutte BC. 2004. Cleft palate: players, pathways, and pursuits. J Clin Invest 113:1676-1678.
39. Nexo E, Hollenberg MD, Figueroa A, Pratt RM. 1980. Detection of epidermal growth factor-urogastrone and its receptor during fetal mouse development. Proc Natl Acad Sci USA 77:2782-2785.
40. Patel RD, Kim DJ, Peters JM, Perdew GH. 2006. The aryl hydrocarbon receptor directly regulates expression of the potent mitogen epiregulin. Toxicol Sci 89:75-82.
41. Pratt RM, Yoneda T, Silver MH, Salomon DS. 1980. Involvement of glucocorticoids and epidermal growth factor in secondary palate development. In: Pratt RM, Christiansen RL, editors. Current research trends in prenatal craniofacial development. New York: Elsevier. p 235-252.
42. Pratt RM, Dencker L, Diewert VM. 1984. 2,3,7,8-Tetrachlorodibenzo-p- dioxin-induced cleft palate in the mouse: evidence for alterations in palatal shelf fusion. Teratog Carcinog Mutagen 4:427-436.
43. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MW, Doetschman T. 1995. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet 11:409-414.
44. Purtois M. 1966. Onset of the acquired potentiality for fusion in the palatal shelves of rats. J Embryol Exp Morph 16:171-182.
45. Schupbach PM, Schroeder HE. 1983. Cell release from the palatal shelves and the fusion line. J Biol Buccale 11:227-241.
46. Shah RM. 1984. Morphological, cellular, and biochemical aspects of differentiation of normal and teratogen-treated palate in hamster and chick embryos. Curr Topics Dev Biol 19:103-135.
47. Shuler CF, Guo Y, Majumder A, Luo RY. 1991. Molecular and morphologic changes during the epithelial-mesenchymal transformation of palatal shelf medial edge epithelium in vitro. Int J Dev Biol 35:463-472.
48. Shuler CF, Halpern DE, Guo Y, Sank AC. 1992. Medial edge epithelium fate traced by cell lineage analysis during epithelial-mesenchymal transformation in vivo. Dev Biol 154:318-330.
49. Smiley GR, Dixon AD. 1968. Fine structure of midline epithelium in the developing palate of the mouse. Anat Rec 161:293-310.
50. Takahara S, Takigawa T, Shiota K. 2004. Programmed cell death is not a necessary prerequisite for fusion of the fetal mouse palate. Int J Dev Biol 48:39-46.
51. Taya Y, O'Kane S, Ferguson MW. 1999. Pathogenesis of cleft palate in TGF-beta3 knockout mice. Development 126:3869-3879.
52. Thomae TL, Stevens EA, Bradfield CA. 2005. Transforming growth factor-beta3 restores fusion in palatal shelves exposed to 2,3,7,8- tetrachlorodibenzo-p-dioxin. J Biol Chem 280:12742-12746.
53. Tyler MS, Koch WE. 1977a. In vitro development of palatal tissues from embryonic mice. II. Tissue isolation and recombination studies. J Embryol Exp Morphol 38:19-36.
54. Tyler MS, Koch WE. 1977b. In vitro development of palatal tissues from embryonic mice. III. Interactions between palatal epithelium and heterotypic oral mesenchyme. J Embryol Exp Morphol 38:37-48.
55. Tyler MS, Pratt RM. 1980. Effect of epidermal growth factor on secondary palatal epithelium in vitro: tissue isolation and recombination studies. J Embryol Exp Morphol 58:93-106.
56. Vargas VI. 1967. Palatal fusion in vitro in the mouse. Arch Oral Biol 12:1283-1288.
57. Walker BE, Crain Jr B. 1960. Effects of hypervitaminosis A on palate development in two strains of mice. Am J Anat 107:49-58.
58. Walker BE, Fraser FC. 1956. Closure of the secondary palate in three strains of mice. J Embryol Exp Morph 4:176-189.
59. Walker BE, Fraser FC. 1957. The embryology of cortisone-induced cleft palate. J Embryol Exp Morph 5:201-209.
60. Waterman RE, Ross LM, Meller SM. 1973. Alterations in epithelial surface of A/Jax mouse palatal shelves prior to and during palatal fusion: a scanning electron microscopic study. Anat Rec 176:361-376.
61. Yamamoto T, Cui XM, Shuler CF. 2003. Role of ERK1/2 signaling during EGF-induced inhibition of palatal fusion. Dev Biol 260:512-521.
62. Zimmerman EF. 1997. Palate. In: Kavlock RJ, Daston GP, editors. Handbook of experimental pharmacology: drug toxicity in embryonic development I. Berlin: Springer-Verlag. p 183-208.